Can a simple calculator help doctors spot early memory decline?
NCT ID NCT06506877
First seen Aug 24, 2026 · Last updated Aug 25, 2026 · Updated 1 time
Summary
This trial tests whether giving primary care doctors two new tools—a cognitive risk calculator built into the electronic health record and a self-administered computer screening test called BACH—helps them identify older adults who may be experiencing early cognitive decline. The study will roll out these tools across eight internal medicine clinics and measure how often doctors use them, whether they lead to more diagnoses and referrals for memory, sleep, and mood issues, and how acceptable and feasible the tools are for both providers and patients. The goal is to see if this practical approach can improve early detection of cognitive problems in routine primary care.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Implementation of a cognitive risk calculator and an automated cognitive screening tool (BACH) in primary care clinics
- What this could lead to
- If effective, this approach could help primary care doctors identify older adults at risk for cognitive decline earlier, leading to timely referrals and better management of conditions like dementia, sleep disorders, and depression.
- What could go wrong
- This is a small, early-stage implementation study focused on provider behavior, not patient outcomes. The tools may not be adopted consistently, and results may not generalize beyond the participating clinics.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 50 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Apr 2024
- Expected to finish
-
Dec 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
Children (under 18), adults (18 to 64) and older adults (65 and over)
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Provider Inclusion Criteria: * Must see adults aged 60 years or older in their practice. * Must be a prescribing provider. Exclusion Criteria: * Provider sees patients at more than one participating study site.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Cognitive risk assessment are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
The full official record for this study. This one lists no contact details, but it is the first place any would appear.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Cleveland Clinic
Cleveland, Ohio, 44195, United States